Development of maraviroc, a CCR5 antagonist for treatment of HIV, using a novel tropism assay
Repository Usage Stats
Published Version (Please cite this version)10.1111/nyas.12777
Publication InfoDemarest, James; Heera, J; Knirsch, C; & van der Ryst, E (2015). Development of maraviroc, a CCR5 antagonist for treatment of HIV, using a novel tropism assay. Annals of the New York Academy of Sciences, 1346(1). pp. 7-17. 10.1111/nyas.12777. Retrieved from http://hdl.handle.net/10161/16076.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Adjunct Assistant Professor in the Department of Immunology
Jim is an accomplished scientific leader recognized internationally for: R&D Innovation: lead and supported research programs, translational research teams, and impacted business strategy for R&D pipeline Business Development: subject matter expert for in-licensing review and advisory role informing business development strategy for R&D and diagnostics Regulatory: written and face-to-face interactions with regulatory author